Abstract
INTRODUCTION
In most of the patients requiring tricuspid valve repair during left-sided valve surgery, tricuspid regurgitation (TR) is secondary to annular dilatation and isolated ring annuloplasty represents the treatment of choice [1] . When, besides enlargement of the tricuspid annulus, TR is caused by prolapse of the leaflets, annuloplasty alone is not enough to restore valve competence and other procedures are necessary to achieve this goal including artificial chordae implantation, leaflet resection, chordal transposition and papillary muscle reimplantation [2] [3] [4] [5] . Similarly, in presence of tethering of the tricuspid leaflets, isolated annuloplasty is not durable and concomitant enlargement of the anterior leaflet has been proposed to avoid valve replacement [6] .
In our Institution, in the circumstances described above, we have been using the so called 'clover technique', to treat TR. This approach consists of stitching together the central part of the free edges of the tricuspid leaflets producing a 'clover' shaped valve.
This method of repair replicates on the right side the principle of the 'edge-to-edge technique' used for mitral regurgitation and it has initially been adopted to treat few cases of complex forms of post-traumatic TR [7, 8] . The encouraging preliminary results obtained in this setting justified its following application in patients with degenerative mitral and tricuspid valve disease and in a limited number of patients with dilated cardiomyopathy (DCM) or advanced right ventricle (RV) dilatation in whom tethering had developed besides annular dilatation [9] .
The aim of this study is to report the long-term results of the clover technique which are still unknown.
METHODS

Study population
The study population includes the first 96 consecutive patients with severe or moderately-severe TR due to complex lesions, who underwent tricuspid repair by means of the 'clover technique' between 2001 and 2014. Out of them, 87 patients (90.6%) were also affected by mitral valve disease needing mitral surgery, before (12 patients, who had their mitral disease previously treated, being redo cases) or at the time of the clover repair (75 patients). The aetiology of the TR was post-traumatic in 9 cases (9.4%), degenerative in 74 (77.1%) and secondary to DCM in 13 patients (13.5%). All patients with post-traumatic tricuspid insufficiency had a history of blunt chest trauma secondary to a motor vehicle accident many years before. Sixty-eight patients with degenerative TR (68/74, 91.8%) were also affected by degenerative mitral regurgitation requiring mitral repair or replacement before or at the time of the tricuspid repair. Finally, the 13 cases of functional TR secondary to DCM were complex patients with severe left ventricular (LV) dysfunction and tethering of the tricuspid leaflets (coaptation depth > 1 cm) associated to annular dilatation. Three of them had ischaemic DCM (in 1 case coronary artery bypass grafting (CABG) had been previously performed) and the remaining 10 presented functional TR secondary to advanced left-sided heart valve disease (5 of them had been previously submitted to mitral or mitroaortic surgery).
For the purpose of this study, the preoperative, intraoperative, postoperative and follow-up data were prospectively entered into a dedicated database and retrospectively reviewed. The Institutional Ethic Committee approved this study and waived individual consent for this retrospective analysis.
Echocardiographic measurements
The severity and mechanism of TR were established by transthoracic (TTE) and transoesophageal echocardiography (TEE) using an integrative approach. The degree of TR was measured by Doppler colour flow imaging and defined as mild 1+/4+ (jet area/ right atrial area <10%), moderate 2+/4+ (jet area/right atrial area 10-20%), moderately-severe 3+/4+ (jet area/right atrial area 20-33%) and severe 4+/4+ (jet area/right atrial area >33%). The vena contracta width at the narrowest portion of the regurgitant jet was also measured in most of the cases. Dilatation and respiratory variation of the inferior vena cava as well as reduction or reversal of systolic flow in the hepatic veins were also used as supportive signs to define the severity of TR [10] . The tricuspid annulus was assessed in late diastole at the time of maximal tricuspid opening in the apical 4-chamber view [11] . The presence of tricuspid annulus enlargement was always described in the echocardiographic notes but the exact annular dimensions were inconstantly reported by the operator, since this was not the standard, particularly in the early phase of this series. The distance between the tricuspid annular plane and the coaptation point of the tricuspid leaflets (coaptation depth) was measured at the time of maximal systolic closure and was used as an index of tethering of the tricuspid leaflets. Right ventricular function was assessed qualitatively and by measuring the peak systolic velocity of the tricuspid annulus with tissue Doppler imaging (S-TDI). According to the measured S-TDI, RV function was classified as normal (S-TDI > _10 cm/s), moderately depressed (S-TDI < _10 cm/s and > _3 cm/s) and severely depressed (S-TDI <3 cm/s). According to this definition, moderate RV dysfunction was present in 27 patients (28.1%). Peak right ventricular systolic pressure as an estimate of pulmonary pressure was calculated by measuring peak tricuspid regurgitant velocity and using the modified Bernoulli equation, with 10 mmHg added for the estimated right atrial pressure.
Follow-up
All patients underwent transthoracic echocardiography before discharge. Clinical and echocardiographic follow-ups were performed in our Institutional outpatient clinic or by means of telephone interview with the patients and the referring cardiologists. Follow-up was 98% complete [median 9 years, interquartile range (IQR) 5.1; 10.9]. Complete follow-up was defined when for a patient we were able to have a clinical and echocardiographic follow-up done within the last 6 months from data collection. Two patients (2%) had a follow-up at 4.5 and 4.2 years after surgery, respectively, but were lost afterwards. The longest follow-up time was 14.6 years. Pre-and post-surgery measurements of systolic pulmonary artery pressure (SPAP) and left ventricular ejection fraction (LVEF) were compared using the Wilcoxon signed-rank test for paired data, while McNemar's test was used to determine if the treatment had an effect on NYHA class and atrial fibrillation.
Statistical analysis
Kaplan-Meier estimates were employed for analyzing longterm survival. Cumulative incidence function (CIF) were computed for cardiac death, with non-cardiac death as competing risk, and for recurrence of TR > _ 2+ or TR > _ 3+, with death as competing risk. For actuarial estimates, data are presented as failure probability ± standard error. Fine and Gray models were used in competing risk analysis for the assessment of predictors of cardiac death and recurrent TR > _ 2+. The selection of variables for the Fine and Gray model was performed by a backward stepwise selection with the Bayesian Information Criterion as selection criteria.
RESULTS
Patient characteristics
Ninety-two patients (95.8%) had TR 3+ or 4+. The mechanism of TR was one or more leaflets prolapse/flail in 81cases (84.3%) due to chordal elongation/rupture (77 patients) or tear of the anterior papillary muscle (4 patients). In particular, the prolapse/flail involved 1 leaflet in 24 patients (24/81, 29.6%), 2 leaflets in 38 (38/81, 46.9%) and all 3 leaflets in 19 (19/81, 23.4%). Leaflet tethering was responsible of TR in 13 patients (13.5%), as a result of advanced right ventricular dilatation. Finally, mixed lesions were present in 2 (2%) post-traumatic cases in whom prolapsing and tethering lesions were simultaneously present in different portions of the valve. All patients but 3 (96.8%) had associated annular dilatation. The mean LVEF and left ventricular end-diastolic diameter were 58 ± 8.8% and 55 ± 8.4 mm, respectively and the majority of patients had pulmonary hypertension. Most of the patients were in NYHA functional class II or III (79.2%) and about one third of them was in atrial fibrillation. One patient had a pacemaker and 2 had an implantable cardioverter-defibrillator (ICD) as secondary prevention. Eighteen patients (18.8%) had previously been submitted to one or more cardiac operations including mitral valve repair or replacement (12 patients), aortic valve replacement (3 patients), CABG (4 patients), atrial septal defect closure (2 patients) and Fallot correction (1 patient). The preoperative clinical and echocardiographic characteristics of the patients are listed in Table 1 .
Procedural data
All patients but one were operated through a conventional median sternotomy with standard cardiopulmonary bypass on moderate hypothermia. In one young case a minimally invasive approach through a right anterior mini-thoracotomy was adopted. The procedure was performed during cardioplegic arrest in all cases except in 2 patients with isolated TR in whom the tricuspid repair was carried out on a beating heart. The tricuspid valve was usually exposed through a conventional oblique right atriotomy. The clover technique has been previously described [7] [8] [9] . Briefly, this procedure consists of stitching together with a 5.0 polypropylene suture, the middle point of the free edges of the tricuspid leaflets producing a 'clover' shaped valve. No pledgets were used to reinforce the suture. All patients but 3 (96.8%) underwent an associated ring (59 patients, 61.5%) or suture (34 patients, 35.4%) annuloplasty to stabilize the clover repair. In particular, a Carpentier-Edwards semi-rigid ring was implanted in 15 patients, a St. Jude Medical Tailor flexible ring in 16, a Medtronic Contour 3D in 2 and an Edwards MC3 semi-rigid ring in 26 patients. The mean size of the prosthetic ring was 32.5 ± 2.70. An isolated tricuspid repair was performed in 14 patients with a mean cross-clamp time of 24 ± 8.4 min. Concomitant procedures were performed in 82 patients (85.4%): mitral valve repair (50 patients), mitral valve replacement (25 patients), CABG (7 patients), radiofrequency ablation of atrial fibrillation (17 patients), suture of atrial septal defect or patent foramen ovalis (8 patients), aortic valve repair/replacement (6 patients) and pulmonary valve replacement (1 patient).
Clinical hospital outcomes
Overall hospital mortality was 7.2% (7/96 patients). The cause of death was low cardiac output syndrome in 3 patients, stroke in 1 (with calcified ascending aorta) and sepsis followed by multiple organ failure in 3 patients. Among the patients who died, 3 were redo cases (1 previous CABG and 2 mitral surgery). Postoperative complications are reported in Table 2 .
Echocardiography at hospital discharge
A TTE was performed at discharge in all hospital survivors. For the 7 patients who died in the hospital, the last TTE before death was considered. No residual TR was present in 53 (55.2%) patients, mild (1+) TR observed in 39 (40.6%) and moderate TR (2+/4+) in 4 patients (4.1%).
Follow-up
Clinical outcomes. At 10 and 12 years, overall survival was 77.5 ± 4.7 and 71.6 ± 7.22% respectively. CIF of cardiac death with noncardiac death as competing risk at 12 years was 16 ± 4.1% [95% confidence interval (95% CI) 9.5; 25.7] (Fig. 1) . During follow-up, 13 patients died (13/89 hospital survivors, 14.6%) and the cause of death was cardiac related in 7 of them: congestive heart failure (5 patients), sudden death (1 patient) and acute preoperative LVEF (HR 0.9, 95% CI 0.8-0.9, P = 0.02) showed statistical significance at multivariable analysis. During follow-up only 1 patient required a new cardiac operation due to severe late TR. The patient underwent tricuspid valve replacement with a bioprosthesis (Carpentier-Edwards n.29) 4 years after the initial clover repair and a following (10 years after) transcatheter valve-in-valve procedure due to the degeneration of the bioprosthesis.
At the last follow-up NYHA III or IV was documented in 14.6% of the patients (13/89) compared to 46.8% (45/96) at baseline (P < 0.001). Atrial fibrillation was present in 27 (30%) cases and 10 (11.2%) patients underwent pacemaker and/or ICD implantation 7 months to 6 years after surgery. In particular, 1 patient received an ICD, 2 patients an ICD-cardiac resynchronization therapy and 7 patients a pacemaker for atrioventricular block (2 cases), slow AF (3 cases) or following AV node ablation for refractory atrial fibrillation (2 cases).
Recurrence of tricuspid regurgitation. At 12 years the CIF of TR > _ 3+ with death as competing risk was 1.2 ± 1.2% (95% CI 0.1-5.8). When TR > _ 2+ was considered, the CIF of this event with death as competing risk was 17 ± 4.3% at 10 years (95% CI 9.8-26.6) and 28 ±7.7% at 12 years (95% CI 14.3-43.5) (Fig. 2) . Univariable predictors of recurrent TR > _ 2+ were preoperative LVEF (HR 0.9, 95% CI 0.9-1, P = 0.05) and previous cardiac surgery (HR 2.7, 95% CI 1-7.1, P = 0.03). However, both of them did not reach a statistical significance at mutivariate analysis (Table 3) . At the last echocardiogram, 77.5% of hospital survivors (69/89 patients) had no or mild TR, and 20.2% (18/89 patients) showed moderate (2+/4+) tricuspid insufficiency. Only 2 patients (2.2%) had recurrent TR > _ 3+. In both of them a clover repair combined with ring annuloplasty (Carpentier semi-rigid ring n.36) had been performed to treat severe posttraumatic TR.
In 1 case a tricuspid valve replacement was required 4.1 years after the initial repair. In this patient, at reoperation, a partial dehiscence of the clover stitch was found together with an important fibrotic retraction of the leaflets (in particular of the septal one). The second patient developed recurrent severe TR 14 years after surgery and is waiting for tricuspid valve replacement.
The 18 patients with moderate (2+) TR at follow-up had been submitted to the clover technique for post-traumatic regurgitation in 1 case, degenerative tricuspid disease with prolapsing lesions in 15 patients and functional TR with severe leaflet tethering in the remaining 2. Among those 18 patients, 5 had an implantable pacemaker and/or ICD-cardiac resynchronization therapy implanted before (1 patient) or after (4 patients) the clover repair. The type of annuloplasty had no impact on the recurrence of TR (P = 0.37). Mean tricuspid valve area and gradient were 4.3 ± 0.6 cm 2 and 2.8 ± 1.4 mmHg. At the last follow-up an important decrease in the SPAP (30 ± 7.6) compared to baseline (50 ± 12.8) was observed (P < 0.0001).
DISCUSSION
The main finding of this observational study is that the clover technique provides durable results at long-term (up to 14 years) in complex forms of TR due to severe prolapse or tethering of the leaflets in the context of traumatic, degenerative or functional TR.
Initially introduced to address TR secondary to blunt chest trauma [7] this method of repair has been subsequently extended to degenerative TR with multiple prolapse/flail of the tricuspid leaflets and to manage severe leaflet tethering in presence of advanced remodelling of the right ventricle [8] . We have previously reported the mid-term results of this approach in the above mentioned settings [9] . More recently other authors have described the adoption of the clover technique in other unusual and heterogeneous forms of TR such as endomyocardial biopsy-induced TR [12] , TR due to pacemaker leads [13] and post-endocarditis TR [14] . Those new indications confirm that when TR cannot be fixed by a simple ring annuloplasty because the lesions involve the leaflets, the clover approach represents an attractive solution able to restore valve competence in a very simple way.
In our opinion the clover repair is not indicated when the mechanism of TR is pure annular dilatation where a well performed ring annuloplasty is usually enough to treat valve incompetence. On the other hand, if leaflet prolapse/flail or tethering are associated, other reconstructive procedures such as the clover technique have to be added to the annuloplasty to restore the competence of the valve [2, 4, 5, 15] . Leaflet lesions like prolapse and tethering may even be concomitantly present in the same patients as it occurs in post-traumatic TR. Indeed, after a blunt chest trauma, sudden rupture of a papillary muscle or primary chordae may happen, leading to acute severe TR. If tricuspid insufficiency is well tolerated, these patients are often followed under medical therapy in order to delay the time of surgery because of the potential need of valve replacement at a very young age. However, medical therapy does not prevent progressive dilatation of the right ventricle which leads to tethering of the non-prolapsing leaflets. Therefore, the final mechanism of TR eventually becomes a combination of annular dilatation, flail and tethering involving different leaflets of the valve. We started to adopt the clover repair specifically in post-traumatic TR because of its unique feature of fixing multiple and 'opposite' lesions (prolapse and tethering) with a single surgical act. Although posttraumatic TR has been addressed also with several other approaches, including resection, chordal transposition, muscle reimplantation and artificial chordae [2, 3, 5] , suboptimal results have been described in those series and the rate of valve replacement has been high [2, 5, 16, 17] .
In our study, 9 patients with post-traumatic TR were included. Valve competence was immediately restored in all cases and excellent results were confirmed at long-term in 7 of them (77.7%).
Two patients showed recurrence of severe TR at 4.5 and 14 years after surgery, respectively. In our opinion, even the 14-year durability registered in this second patient represents a good outcome of this repair considering the complexity of the lesions, the young age of the patient and the avoidance of valve replacement for about 15 years.
The vast majority of the patients included in this study had severe TR due to leaflet prolapse in the context of degenerative disease of both the mitral and the tricuspid valve [10, 18, 19] . Very few presented with isolated degenerative TR. In most of those degenerative TR cases at least 2 leaflets were involved. Immediate results in this subgroup were excellent with only 2 patients showing moderate (2+/4+) residual TR at hospital discharge. At long-term the vast majority of them had no or mild TR and none presented with recurrent TR greater than moderate (2+/4+).
Finally, we have used the clover technique in 13 patients with severe functional TR and leaflet tethering (coaptation depth >1 cm) secondary to important right ventricular dilatation in the context of ischaemic DCM or long-lasting left-sided heart valve disease. Ring annuloplasty alone is not durable in presence of tethering of the tricuspid leaflets [15, 20] . Enlargement of the anterior tricuspid leaflet with a pericardial patch is useful in those patients although long-term follow-up is awaited [6] . In presence of tethering, we forced the coaptation by suturing the free margins of the tricuspid leaflets this being a much quicker procedure in patients in whom long cross-clamp times can be deleterious. The use of an annuloplasty ring is mandatory in these circumstances to reduce as much as possible the tension on the leaflets. Restoration of valve competence and reverse right ventricular remodelling might further decrease leaflet stress. Although outcomes in this specific subgroup were comparable to the posttraumatic and degenerative ones, we believe that this is the setting where a word of caution is particularly necessary in consideration of the limited number of patients treated and the natural history of the underlying disease.
Overall, for the first time, this study confirmed the durability at long-term of this approach with a cumulative incidence of recurrence of severe TR of only 1.2% at 12 years. Although a mild progression of TR occurred in about 16% of the hospital survivors over the years, the grade of regurgitation documented in those patients at the last echocardiogram was no more than moderate (2+/4+). The distribution of those patients was similar in the 3 different etiology subgroups and no independent predictors of TR > _ 2+ at follow-up were identified. Indeed, although previous cardiac surgery and LVEF were identified as risk factors for this event at the univariable analyses, both did not reach statistical significance at multivariable analyses. Long-term echocardiographic data are reassuring as far as the risk of developing late stenosis is concerned. Indeed, both mean tricuspid valve area and gradients remained in the normal range without significant changes compared to those measured at discharge.
Interestingly pacemaker and ICD implantation at follow-up could be performed whenever required without major technical issues.
From a clinical point of view, we believe that rather than looking at the overall survival, it is important to assess the rate of cardiac death. Competing risk analyses was used for this end point showing a 16% CIF of cardiac mortality. Not surprisingly age and lower LVEF were the only independent predictors of this event.
Finally, at the last follow-up an important decrease in the SPAP compared to baseline was observed as well as a significant symptomatic improvement. The concomitant procedures performed mainly on the mitral valve played most likely the major role in determining those improvements.
Limitations
In terms of data collection this study has all the limitations of every retrospective study. The exact dimensions of the tricuspid annulus in millimetres were not systematically measured, particularly at the beginning of this series, and therefore, they could not be used for analysis. RV dimensions and function were not consistently assessed at follow-up and could not be compared with the preoperative values. In addition, all patients included in this series had at least one echocardiographic follow-up performed within the previous six months. However, one third of them had this exam performed outside our Institution in their regional hospital and the echo reports were simply sent to our attention.
Finally, the absence of a control group (wherein only a TV annuloplasty has been performed) and the fact that the assessment of the tricuspid valve was basically done just at the last echocardiographic follow-up (reflecting thereby only the tricuspid valve function at one moment) are both limitations of the study. Moreover, we are not able to provide in details how much the decrease in diuretic requirement was at follow-up compared to the preoperative amounts.
CONCLUSION
In conclusion, long-term clinical and echocardiographic data indicate that the clover repair is an effective and durable technique for the surgical treatment of TR due to lesions which are unlikely to be fixed by annuloplasty alone. In those difficult settings, this approach represents a useful adjunct to the current surgical armamentarium and it might significantly increase the rate of repair and reduce the incidence of suboptimal early and late results.
